Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

VDAC1, mitochondrial dysfunction, and Alzheimer's disease.

Varda Shoshan-Barmatz1, Edna Nahon-Crystal1, Anna Shteinfer-Kuzmine1

  • 1Department of Life Sciences and the National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.

Pharmacological Research
|March 20, 2018
PubMed
Summary

Mitochondrial dysfunction, specifically the protein VDAC1, plays a key role in Alzheimer's disease (AD) pathogenesis. Targeting VDAC1 offers a novel therapeutic strategy to inhibit neuronal cell death in AD.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MAVS as a Key Regulator of Tumor Proliferation, Survival, the Tumor Microenvironment, and Immunity.

Biomolecules·2026
Same author

Disrupting VDAC1-tubulin interaction uncovers crosstalk between mitochondrial and microtubule functions with implication to cancer therapy.

Cellular and molecular life sciences : CMLS·2026
Same author

Erratum: Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effects.

Molecular therapy. Oncology·2026
Same author

Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effects.

Molecular therapy. Oncology·2026
Same author

p53 Interacts with VDAC1, Modulating Its Expression Level and Oligomeric State to Activate Apoptosis.

Biomolecules·2026
Same author

Signaling pathways regulating VDAC1 overexpression associated with apoptosis, pyroptosis, and ferroptosis.

Cell communication and signaling : CCS·2026

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Alzheimer's disease (AD) is an age-related neurodegenerative disorder with unclear etiology.
  • Mitochondrial dysfunction, characterized by metabolic changes and increased oxidative stress, is an early event in AD.
  • Amyloid-β (Aβ) and hyperphosphorylated tau are implicated but do not fully explain AD pathogenesis.

Purpose of the Study:

  • To review the involvement of mitochondrial dysfunction in Alzheimer's disease.
  • To specifically examine the role of the voltage-dependent anion channel 1 (VDAC1) in AD pathogenesis.
  • To explore VDAC1 as a potential therapeutic target for inhibiting neuronal cell death.

Main Methods:

  • Review of existing literature on mitochondrial dysfunction and VDAC1 in AD.
Keywords:
Alzheimer's diseaseApoptosisMetabolismMitochondriaVoltage-dependent anion channel 1

Related Experiment Videos

  • Analysis of VDAC1's interactions with key AD-related proteins (Aβ, tau, γ-secretase).
  • Examination of VDAC1 expression levels in post-mortem AD brains and transgenic AD mouse models.

    • Main Results:

    • VDAC1 is a multi-functional protein regulating cellular metabolism, calcium homeostasis, oxidative stress, and apoptosis.
    • VDAC1 interacts with over 150 proteins, including those central to AD pathology, and contributes to their toxicity.
    • Elevated VDAC1 levels in AD brains and models correlate with neuronal cell destruction, as VDAC1 overexpression induces cell death.

    Conclusions:

    • VDAC1 is a critical hub protein linking mitochondrial dysfunction to AD pathogenesis.
    • Targeting VDAC1's pro-apoptotic activity presents a novel therapeutic strategy for Alzheimer's disease.
    • VDAC1 may also be involved in the links between AD, diabetes, and cancer.